The University of Queensland

A randomised single-blind placebo-controlled study to investigate the safety tolerability immunogenicity pharmacokinetics and pharmacodynamics of intravenous infusion of GSK933776 in Alheimers patient (2008–2009)

Grant type:

Glaxo Smith Kline Aust. Pty Ltd

Researchers:

• 

  Professor Gerard Byrne

  Mayne Professor of Psychiatry
  

  Medical School (Office & AME)

  Faculty of Medicine

Funded by:

GlaxoSmithKline Australia Pty Ltd